All Industries

Top Biotech Companies

3,960 Biotech companies, sorted by total funding raised.

Colossal Biosciences

De-extinction and genetic engineering company working to bring back the woolly mammoth and other ...

Dallas, United States51–200Biotech, Genetics
Series D·$583.0M·Sep 2025
Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage biotech developing novel small molecule medicines using s...

Cambridge, United StatesBiotech, Healthcare
Growth Equity·$572.0M·Sep 2023
Orca Bio

Clinical-stage biotech developing high-precision allogeneic cell therapies to replace diseased bl...

Menlo Park, United States51–200Biotech, Healthcare
Series F·$567.0M·Dec 2025
BT
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, oncology
Private Equity·$555.0M·Jan 2024
KardiganIPO

Cardiovascular drug development company focused on making cardiovascular disease curable and prev...

South San Francisco, United States51–200Biotech, Healthcare
Series B·$554.0M·Oct 2025
ElevateBio

ElevateBio is a biotech company powering transformative cell and gene therapies through integrate...

Cambridge, United States201–500Biotech
Venture Round·$551.0M·May 2023
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
Convertible·$550.1M·Aug 2025
Arcus BiosciencesIPO

Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...

Hayward, United States201–500Biotech, Healthcare
Corporate Round·$544.0M·Jan 2024
Guardant HealthIPO

Guardant Health is an oncology company.

Palo Alto, United States1001–5000Biotech, Healthcare
Series E·$540.0M·May 2017
Rakuten Medical

Global biotechnology company developing and commercializing precision, cell-targeting therapies b...

San Diego, United StatesBiotech, Life Sciences
Series F·$535.0M·Jan 2026
GS Holdings (formerly Genuity Science (WuXi Nextcode Genomics – Fjord))

Genomics and data analytics company providing drug discovery and development services to global b...

Cambridge, United StatesBiotech, Healthcare
Series C·$530.0M·Nov 2018
Beam TherapeuticsIPO

Biotechnology company developing precision genetic medicines through proprietary base editing tec...

Cambridge, United States201–500Biotech, Gene Editing
Growth Equity·$528.0M·Feb 2026
Relay TherapeuticsIPO

Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$520.0M·Dec 2018
Aviceda

World leader in glyco-immune checkpoint therapeutics developing immune-mediated therapies for pat...

Cambridge, United States51–200Biotech
Series C·$507.5M·Jan 2025
MetseraAcquired

Clinical-stage biopharmaceutical company developing next-generation oral and injectable medicines...

New York, United States11–50Biotech, Obesity
Series B·$505.0M·Nov 2024
ADC Therapeutics SA Common SharesIPO

Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.

Lausanne, Switzerland201–500Biotech, Healthcare
Series E·$501.0M·Jun 2019
Annexon, Inc.

R&D company with 1 SBIR/STTR awards from Department of Health and Human Services.

South San Francisco, United States1–10Biopharmaceutical, Biotech
Series E·$500.0M·Nov 2025
Summit Therapeutics Inc.IPO

Biopharmaceutical oncology company focused on discovery, development, and commercialization of ca...

Miami, United States51–200Biotech, Healthcare
Corporate Round·$500.0M·Oct 2025
Carmot TherapeuticsAcquired

Carmot Therapeutics was a clinical-stage biotech developing GLP-1-based therapeutics for obesity ...

Berkeley, United States11–50Biotech, Therapeutics
Series E·$497.0M·May 2023
RAPT TherapeuticsIPO

Clinical-stage biopharmaceutical developing immune-targeting therapeutics for inflammatory and im...

San Francisco, United States51–200Biotech, Healthcare
Private Equity·$497.0M·Oct 2025
Biohaven Ltd. Common SharesIPO

Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...

New Haven, United States201–500Biotech, Healthcare
Venture Round·$493.6M·Aug 2020
GenentechIPO

Biotechnology company that discovers and develops medicines for serious, life-threatening disease...

San Francisco, United States10001+Biotech, Drug Discovery
Corporate Round·$492.3M·Feb 1990
ApellisIPO

Global biopharmaceutical company developing targeted C3 therapies to treat diseases driven by exc...

Waltham, United States501–1000Biotech
Corporate Round·$490.1M·Feb 2023
Piramal Pharma

India-based pharmaceutical company offering CDMO services, critical care products, and consumer h...

Mumbai, IndiaBiotech, Healthcare
Corporate Round·$490.0M·Jun 2020
Kallyope

Kallyope leverages unique insights into neural signaling pathways to develop innovative medicines...

New York, United States51–200Biotech, Drug Discovery
Grant·$487.2M·May 2023